Tumor rejection was delayed and partially compromised by depleting let-7 miRNAs in responding CD8 T cells (Fig. 2f), confirming the critical role of let-7 deficiency in the dysfunction of CTLs upon activation in vivo. This evidence concerns the gene CD8A and neoplasm.